Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia?
Angiogenesis is involved in the pathogenesis of B-cell chronic lymphocytic leukemia (CLL), and high microvascular density has been found in CLL to be associated with a poor prognosis. In this study, we assessed serum levels of adiponectin in 69 patients with Binet stage A B-CLL, and these values wer...
Saved in:
Main Authors: | Stefano Molica, Giovanna Digiesi, Angelo Vacca, Rosanna Mirabelli, Katia Todoerti, Caterina Battaglia, Fortunato Morabito, Antonino Neri, Domenico Ribatti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2009/287974 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of Immunity by Antiangiogenic Molecules in Cancer
by: Magali Terme, et al.
Published: (2012-01-01) -
Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
by: Mitsuko Furuya, et al.
Published: (2011-01-01) -
Chronic Lymphocytic Leukemia and Myelofibrosis
by: Fares Darawshy, et al.
Published: (2018-01-01) -
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01) -
Chronic Lymphocytic Leukemia-Associated Cholangiopathy
by: Jake Mann, et al.
Published: (2011-01-01)